MPHOSPH8 | M-phase phosphoprotein 8 | | | | | | Expressed in all |
PSPC1 | Paraspeckle component 1 | Transcription factors
| | | | | Expressed in all |
CRYL1 | Crystallin, lambda 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
SAP18 | Sin3A-associated protein, 18kDa | Transporters
| | | | | Expressed in all |
ZDHHC20 | Zinc finger, DHHC-type containing 20 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
SGCG | Sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SPATA13 | Spermatogenesis associated 13 | Plasma proteins
| | | | | Expressed in all |
C1QTNF9 | C1q and tumor necrosis factor related protein 9 | Predicted secreted proteins
| | | | | Tissue enhanced |
PARP4 | Poly (ADP-ribose) polymerase family, member 4 | Enzymes
| | | | | Expressed in all |
AMER2 | APC membrane recruitment protein 2 | | | | | | Tissue enriched |
RNF6 | Ring finger protein (C3H2C3 type) 6 | Disease related genes Plasma proteins
| | | | | Expressed in all |
RASL11A | RAS-like, family 11, member A | | | | | | Expressed in all |
GTF3A | General transcription factor IIIA | Transcription factors
| | | | | Expressed in all |
MTIF3 | Mitochondrial translational initiation factor 3 | Mitochondrial proteins
| | | | | Expressed in all |
PDX1 | Pancreatic and duodenal homeobox 1 | Disease related genes Transcription factors
| | | | | Tissue enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | | Group enriched |
PAN3 | PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) | | | | | | Expressed in all |
FLT1 | Fms-related tyrosine kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
MTUS2 | Microtubule associated tumor suppressor candidate 2 | | | | | | Tissue enriched |
SLC7A1 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 | Predicted membrane proteins Transporters
| | | | | Mixed |
HMGB1 | High mobility group box 1 | Plasma proteins
| | | | | Expressed in all |
USPL1 | Ubiquitin specific peptidase like 1 | Enzymes
| | | | | Expressed in all |
HSPH1 | Heat shock 105kDa/110kDa protein 1 | Cancer-related genes
| | | | | Expressed in all |
PDS5B | PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) | | | | | | Expressed in all |
STARD13 | StAR-related lipid transfer (START) domain containing 13 | Mitochondrial proteins Plasma proteins
| | | | | Mixed |
NBEA | Neurobeachin | Plasma proteins Predicted membrane proteins
| | | | | Mixed |
DCLK1 | Doublecortin-like kinase 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
POSTN | Periostin, osteoblast specific factor | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COG6 | Component of oligomeric golgi complex 6 | Disease related genes
| | | | | Expressed in all |
MRPS31 | Mitochondrial ribosomal protein S31 | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
NAA16 | N(alpha)-acetyltransferase 16, NatA auxiliary subunit | | | | | | Expressed in all |
AKAP11 | A kinase (PRKA) anchor protein 11 | Plasma proteins
| | | | | Expressed in all |
TNFSF11 | Tumor necrosis factor (ligand) superfamily, member 11 | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
EPSTI1 | Epithelial stromal interaction 1 (breast) | Predicted membrane proteins
| | | | | Expressed in all |
ENOX1 | Ecto-NOX disulfide-thiol exchanger 1 | | | | | | Mixed |
GTF2F2 | General transcription factor IIF, polypeptide 2, 30kDa | Enzymes
| | | | | Expressed in all |
COG3 | Component of oligomeric golgi complex 3 | Predicted secreted proteins
| | | | | Expressed in all |
SPERT | Spermatid associated | | | | | | Tissue enriched |
LCP1 | Lymphocyte cytosolic protein 1 (L-plastin) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
LRRC63 | Leucine rich repeat containing 63 | | | | | | Group enriched |
ESD | Esterase D | Enzymes Plasma proteins
| | | | | Expressed in all |
HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
SUCLA2 | Succinate-CoA ligase, ADP-forming, beta subunit | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
MED4 | Mediator complex subunit 4 | | | | | | Expressed in all |
RB1 | Retinoblastoma 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
FNDC3A | Fibronectin type III domain containing 3A | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
SETDB2 | SET domain, bifurcated 2 | Enzymes Plasma proteins
| | | | | Mixed |
RNASEH2B | Ribonuclease H2, subunit B | Disease related genes
| | | | | Expressed in all |
INTS6 | Integrator complex subunit 6 | | | | | | Expressed in all |
ATP7B | ATPase, Cu++ transporting, beta polypeptide | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |